Our work also sheds new light on the mechanism underlying LUBAC in regulating HIF1α homeostasis, tumor angiogenesis and lung tumorigenesis, making LUBAC an attractive therapeutic target for lung carcinoma. This evidence concerns the gene HIF1A and lung carcinoma.